Peirong Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Peirong Chen has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Bingjie Ma
College of Animal Science and Technology, Xinyang Agriculture and Forestry University, Xinyang, China
2 shared publicationsHaigang Wu
College of Animal Science and Technology, Xinyang Agriculture and Forestry University, Xinyang, China
2 shared publicationsZhili Li
College of Animal Science and Technology, Xinyang Agriculture and Forestry University, Xinyang, China
2 shared publications- Haigang Wu
Department of Veterinary Medicine (Veterinary Imaging and Diagnostic Ultrasound), College of Animal Science and Veterinary Medicine, Xinyang Agriculture and Forestry University, Xinyang 464000, China
1 shared publication - Jinni Liu
Xinyang Agr & Forestry Univ, Coll Anim Sci & Vet Med, Xinyang 464000, Peoples R China
1 shared publication Kaiwei Deng
College of Animal Science and Veterinary Medicine Xinyang Agriculture and Forestry University 464000 Xinyang People's Republic of China
1 shared publication
Latest Publications
- Open Access
- 13 April 2023
- Published by Elsevier in Poultry Science
- Vol. 102 (10) , 102713
Effects of melittin on production performance, antioxidant function, immune function, heat shock protein, intestinal morphology, and cecal microbiota in heat-stressed quails
- 13 April 2023
- Published by Elsevier in Poultry Science
- Vol. 102 (10) , 102713
Open AccessEffects of melittin on production performance, antioxidant function, immune function, heat shock protein, intestinal morphology, and cecal microbiota in heat-stressed quails
- Open Access
- 4 January 2023
- Published by Agricultural Research Communication Center in Indian Journal of Animal Research
- Vol. 58 (Of) , 545-549
Research Progress in the Preparation of Enrofloxacin for Use in Veterinary Medicine
Enrofloxacin is a special antibacterial agent for animals and is a synthetic third-generation fluoroquinolone broad-spectrum antibacterial agent. It has excellent antibacterial effects and is widely used in clinical practice. However, the solubility of enrofloxacin is extremely low and this has greatly limited its clinical use. We assessed progress in overcoming this deficiency by tracking pharmaceutical alterations to enrofloxacin in vivo delivery systems. We used the keywords ‘enrofloxacin’, ‘pharmaceuticals’ and ‘preparations’ to assess relevant literature sources collected in CNKI, Wanfang, Vepsa, China Patent Information Network, PubMed, Web of Science and other domestic and foreign databases from 2010 to 2022 to summarize the research progress of enrofloxacin pharmaceutics. A total of 62 valid literature were retrieved and we found that pharmaceutic technologies successfully were able to increase enrofloxacin solubility, palatability, bioavailability and half-life. The continuous development and promotion of new drug formulations and new materials will give enrofloxacin preparations broad application prospects in veterinary medicine.
- 4 January 2023
- Published by Agricultural Research Communication Center in Indian Journal of Animal Research
- Vol. 58 (Of) , 545-549
Open AccessResearch Progress in the Preparation of Enrofloxacin for Use in Veterinary Medicine
Enrofloxacin is a special antibacterial agent for animals and is a synthetic third-generation fluoroquinolone broad-spectrum antibacterial agent. It has excellent antibacterial effects and is widely used in clinical practice. However, the solubility of enrofloxacin is extremely low and this has greatly limited its clinical use. We assessed progress in overcoming this deficiency by tracking pharmaceutical alterations to enrofloxacin in vivo delivery systems. We used the keywords ‘enrofloxacin’, ‘pharmaceuticals’ and ‘preparations’ to assess relevant literature sources collected in CNKI, Wanfang, Vepsa, China Patent Information Network, PubMed, Web of Science and other domestic and foreign databases from 2010 to 2022 to summarize the research progress of enrofloxacin pharmaceutics. A total of 62 valid literature were retrieved and we found that pharmaceutic technologies successfully were able to increase enrofloxacin solubility, palatability, bioavailability and half-life. The continuous development and promotion of new drug formulations and new materials will give enrofloxacin preparations broad application prospects in veterinary medicine.